Data / Form D filings / Arch Biopartners Inc.
Arch Biopartners Inc.: Form D filings
Arch Biopartners Inc., a biotechnology company in Toronto, Ontario, Canada, filed 4 Form D notices with the SEC between 2014 and 2015. The latest, on January 22, 2015, reports $265,000 sold of a $265,000 offering to 6 investors.
Find out what Arch Biopartners Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 174 SPADINA AVENUE, SUITE 502A, Toronto, Ontario, Canada, M5T 2
- Phone
- (647) 428-7031
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1600660
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 22, 2015 | New notice | $265,000 | $265,000 | $0 | 6 | Jan 12, 2015 | sec.gov |
| Aug 18, 2014 | New notice | $155,519 | $155,519 | $0 | 4 | Aug 5, 2014 | sec.gov |
| Apr 4, 2014 | New notice | $140,000 | $140,000 | $0 | 3 | Mar 25, 2014 | sec.gov |
| Mar 6, 2014 | New notice | $70,000 | $70,000 | $0 | 2 | Feb 25, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Adrian Haigh | Director | |
| Richard Muruve | Executive Officer, Director | |
| Daniel Muruve | Executive Officer | |
| Andrew Bishop | Executive Officer, Director | |
| Richard Rossman | Director | |
| Claude Allary | Director | |
| Conor Gunne | Director |
Every Form D from the week of Jan 19, 2015 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Arch Biopartners Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.